Improving consumer access to medicines: innovative medicines reclassification in New Zealand (NZ)

• In: 8F5 - Short Oral Communication of the Social and Administrative Pharmacy Section on Monday, 8 October 2012, 14:00-17:00
• At: Amsterdam (the Netherlands) (2012)
• Type: Presentations + Posters
• By: GAULD, Natalie (University of Auckland, General Practice and Primary Healthcare, Auckland, New Zealand)
• Co-author(s): Kelly, F.J. (University of Auckland, Auckland, New Zealand)
  Emmerton, L. (Curtin University, Perth, Australia)
  Buetow, S. (University of Auckland, Auckland, New Zealand)
  
• Abstract:

  Background: Prescription to non-prescription reclassification has slowed in many developed countries. However, despite a small population and negative pharmaceutical industry environment, reclassification is progressing in NZ, with first-in-world reclassifications of oseltamivir, famciclovir and calcipotriol.Objective: To ascertain why NZ is one

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login